Statistics for MSLs
About this event:
This workshop will show participants how to interpret results from randomised clinical trials. Professor Allan Hackshaw will lead the training session. He is Professor of Epidemiology & Medical Statistics at University College London, and Deputy Director of the Cancer Research UK & UCL Cancer Trials Centre, one of the largest cancer trials units in the UK (please see a biography of Prof Allan Hackshaw below).
For those of you at the 2018 Annual Conference you will have had a taster of what to expect in this comprehensive one-day training course. The course will include the following core topics:
- Brief outline of a randomised trial, and its key design strengths.
- Measuring efficacy (effect sizes such as relative risk and hazard ratio), and understanding Kaplan-Meier curves.
- Supporting statistics: 95% confidence intervals and properly understanding p-values (and how they are misinterpreted)
- How can a treatment effect be both big and small?
- Measuring safety/toxicity and drug adherence.
The day will be based around interactive sessions, with continuous dialogue between the presenter and each other. Examples from the published literature will be used throughout and 2 clinical papers will be sent to delegates a few days beforehand to review in preparation for the day.
Date: Thursday 22nd November 2018
Time: 10am – 4pm
Venue: Hilton Birmingham Metropole, Pendigo Way, Marston Green, Birmingham B40 1PP, Tel: 0121 780 4242
Registration cost: £150 MSLA Members / £200 Non-members
Cancellation policy: Please see below.
Please register quickly to avoid disappointment. Places will be limited to 30 maximum and will be on a first come, first served basis.
Prof Allan Hackshaw
Allan Hackshaw is Professor of Epidemiology & Medical Statistics at University College London, and Deputy Director of the Cancer Research UK & UCL Cancer Trials Centre, one of the largest cancer trials units in the UK. He has >22 years’ experience in the design, conduct and interpretation of clinical trials, observational studies and systematic reviews, in a variety of disease areas (including cancer treatments, prognostic factors in cancer, antenatal & cancer screening; and tobacco and health). This has included major cohort/case-control studies, and phase II and large phase III trials.
He has been a key co-investigator on successful grant funding applications (~£56 million in total), and published 150 articles in journals and book chapters, plus sole or first author of four textbooks, including ‘A Concise Guide to Clinical Trials’ (Wiley/Blackwells). He is involved in postgraduate courses (on evidence-based medicine) at UCL, London School of Economics and Harvard. He has been a member of national and international scientific grant funding and data monitoring committees. In 2012 he was chosen as one of the top 40 academic role models in biomedicine at UCL.
MSLA Registration Cancellation Policy, administration and liability:
Admission to the meeting will be strictly by pre-registration and full settlement of fees. Anyone presenting themselves on the day will not be granted admission. There are no exception to this rule due to security and parity of rules for all.
Please make every effort to pass on your place to a colleague and inform us of their details if you cannot attend.
Up to four weeks before the meeting: 100% of the registration fees (less 10% PayPal fees & administration costs).
Up to two weeks before the meeting: 50% of the registration fees (less 10% PayPal fees & administration costs).
There are no additional concessions and reimbursement will be considered on an individual basis.
Please note that the MSLA will not be responsible for you or your possession whilst you attend a meeting. It is your duty to be vigilant with your own safety and in securing your valuables. Report any issue to the MSLA & the venue.